Prot# 2019-SCAR-01: A Phase 2b/3 Randomized, Prospective, Double-Blind, Within-Subject Vehicle Controlled, Multi-Center Study to Determine the Efficacy and Safety of Granexin® Gel (100 µM and 200 µM concentration) in Reducing Scar Formation in Surgical Wo

Project: Research project

Project Details

Effective start/end date6/25/206/25/23


  • Advanced Clinical LLC (Prot# 2019-SCAR-01 // Prot# 2019-SCAR-01)
  • FirstString Research, Inc (Prot# 2019-SCAR-01 // Prot# 2019-SCAR-01)